Literature DB >> 20871478

Factors affecting the yield of brush cytology for the diagnosis of pancreatic and biliary cancers.

Mansour A Parsi1, Fnu Deepinder, Rocio Lopez, Tyler Stevens, Milan Dodig, Gregory Zuccaro.   

Abstract

OBJECTIVE: Pancreatobiliary malignancies often present as biliary strictures. Biliary brush cytology is an established diagnostic technique in the investigation of such strictures. The main shortcoming of the test, however, is its low sensitivity. The aim of this was to identify factors associated with a positive yield on biliary brush cytology.
METHODS: Consecutive patients who had brush cytology for investigation of biliary strictures from 2005 to 2007 were included. Association of several factors with a positive result on brush cytology was studied using univariable and multivariable logistic regression analyses.
RESULTS: Two hundred eighty patients were evaluated. One hundred nineteen (42.5%) patients had a final diagnosis of malignancy; of whom, 55 had a positive brush cytology (sensitivity, 46%; specificity, 100%). On multivariable analysis, age (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.06-10.4 per 5-year increase), total serum bilirubin levels (OR, 1.3; 95% CI, 1.01-1.6 per 5-unit increase), and presence of a mass on cross-sectional imaging (OR, 11.7; 95% CI 5.1-27.2) were independent predictors of a positive brush cytology result.
CONCLUSIONS: Increasing age, higher serum bilirubin levels, and presence of a mass on cross-sectional imaging are independent factors associated with a positive result on biliary brush cytology. These findings suggest use of complementary tissue acquisition techniques in selected cases.

Entities:  

Mesh:

Year:  2011        PMID: 20871478     DOI: 10.1097/MPA.0b013e3181f3aa96

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures.

Authors:  Udayakumar Navaneethan; Vennisvasanth Lourdusamy; Earl Poptic; Jeffrey P Hammel; Madhusudhan R Sanaka; Mansour A Parsi
Journal:  Dig Dis Sci       Date:  2014-10-25       Impact factor: 3.199

2.  Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.

Authors:  Udayakumar Navaneethan; Norma G Gutierrez; Ramprasad Jegadeesan; Preethi G K Venkatesh; Earl Poptic; Xiuli Liu; Madhusudhan R Sanaka; Sunguk Jang; John J Vargo; Mansour A Parsi
Journal:  Dig Dis Sci       Date:  2013-07-05       Impact factor: 3.199

3.  The diagnostic value of brush cytology alone and in combination with tumor markers in pancreaticobiliary strictures.

Authors:  Ufuk Barış Kuzu; Bülent Ödemiş; Nesrin Turhan; Erkan Parlak; Selçuk Dişibeyaz; Nuretdin Suna; Erkin Öztaş; Muhammet Yener Akpınar; Adem Aksoy; Serkan Torun; Hakan Yıldız; Ertuğrul Kayaçetin
Journal:  Gastroenterol Res Pract       Date:  2015-03-26       Impact factor: 2.260

4.  Evaluation of Intraductal Ultrasonography, Endoscopic Brush Cytology and K-ras, P53 Gene Mutation in the Early Diagnosis of Malignant Bile Duct Stricture.

Authors:  Ping Huang; Hao Zhang; Xiao-Feng Zhang; Xiao Zhang; Wen Lyu; Zhen Fan
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

5.  Comparison of the Diagnostic Performance of Novel Slim Biopsy Forceps with Conventional Biopsy Forceps for Biliary Stricture: A Multicenter Retrospective Study.

Authors:  Eun Suk Jung; Se Woo Park; Jung Hee Kim; Jang Han Jung; Min Jae Yang; Da Hae Park
Journal:  J Pers Med       Date:  2021-01-17

6.  Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.

Authors:  Wei-Ming Chen; Kuo-Liang Wei; Yi-Shing Chen; Pey-Jium Chang; Shui-Yi Tung; Te-Sheng Chang; Hao-Chun Huang; Chein-Heng Shen; Yung-Yu Hsieh; Cheng-Shyong Wu
Journal:  World J Surg Oncol       Date:  2016-05-04       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.